ScoreWhy is Hunan Jingfeng Pharmaceutical Co., Ltd. ?
1
Flat results in Mar 26
- NET PROFIT(HY) At CNY -32.65 MM has Grown at -113.17%
- OPERATING CASH FLOW(Y) Lowest at CNY -23.68 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 17.21%, its profits have fallen by -145.2%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hunan Jingfeng Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hunan Jingfeng Pharmaceutical Co., Ltd.
3.44%
7.00
56.39%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.10%
EBIT Growth (5y)
14.17%
EBIT to Interest (avg)
-1.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
5.50
Sales to Capital Employed (avg)
0.94
Tax Ratio
5.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.30%
ROE (avg)
44.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.38
EV to EBIT
-125.91
EV to EBITDA
-218.70
EV to Capital Employed
21.94
EV to Sales
19.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-17.43%
ROE (Latest)
-3.03%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
PRE-TAX PROFIT(Q)
At CNY 3.64 MM has Grown at 126.88%
NET PROFIT(Q)
At CNY 2.2 MM has Grown at 113.46%
RAW MATERIAL COST(Y)
Fallen by -0.51% (YoY
CASH AND EQV(HY)
Highest at CNY 3,404.91 MM
-11What is not working for the Company
NET PROFIT(9M)
At CNY -30.46 MM has Grown at -113.4%
OPERATING CASH FLOW(Y)
Lowest at CNY -57.96 MM
INTEREST(Q)
At CNY 2.17 MM has Grown at 63.21%
Here's what is working for Hunan Jingfeng Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 3.64 MM has Grown at 126.88%
over average net sales of the previous four periods of CNY -13.56 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 2.2 MM has Grown at 113.46%
over average net sales of the previous four periods of CNY -16.33 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Cash and Eqv
Highest at CNY 3,404.91 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -0.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Hunan Jingfeng Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY -57.96 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
At CNY 2.17 MM has Grown at 63.21%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Footer loading
